From November 17-19, "2023 China National Pharmaceutical Industry Development Conference" was held in Beijing, sponsored by the Ministry of Industry and Information Technology, the National Health Commission, the State-owned Assets Supervision and Administration Commission of the State Council, the National Administration of Traditional Chinese Medicine, the National Medical Products Administration, and the Beijing Municipal People's Government. On the 18th, at the "2023 (40th) Annual Meeting of National Pharmaceutical Industry Information and 2022 China Top 100 Pharmaceutical Industry Forum", one of the main parts of the conference, the list of "2023 Best Industrial Enterprises in China National Pharmaceutical R&D Product Line" was unveiled, and BIOKIN PHARMACEUTICAL was honored with the award again.

The "Best Industrial Enterprises in China National Pharmaceutical R&D Product Line" is the most authoritative and socially influential professional selection in China's pharmaceutical industry, aiming at tracking R&D dynamics in real time and digging out domestic pharmaceutical innovation benchmark enterprises, and the list is authoritatively released by China National Pharmaceutical Industry Information Center at the annual meeting of the National Pharmaceutical Industry Information Conference, and this is the 9th consecutive year for which BIOKIN PHARMACEUTICAL has won the title of the "Best Industrial Enterprises in China National  Pharmaceutical R&D Product Line".